Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

Biomaterials

Volumn 35, Issue 10, 2014, Pages 3331-3339

  Li, Li ^a   Gu, Wenyi ^a   Chen, Jiezhong ^a,b   Chen, Weiyu ^a   Xu, Zhi P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Apoptosis; Co delivery system; Electrostatic assembly; Layered double hydroxide

Indexed keywords

5-FLUOROURACIL (5-FU); ANION EXCHANGE CAPACITY; CELLULAR DELIVERY; CO DELIVERIES; ELECTROSTATIC ASSEMBLY; INTERLAYER SPACINGS; LAYERED DOUBLE HYDROXIDES; MITOCHONDRIAL DAMAGE;

CELL CULTURE; CELL DEATH; DISEASES;

NANOPARTICLES;

CELL DEATH SMALL INTERFERING RNA; FLUOROURACIL; HYDROXIDE; LAYERED DOUBLE HYDROXIDE NANOPARTICLE; NANOPARTICLE; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANION EXCHANGE; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER THERAPY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOSOME; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; INTERNALIZATION; MULTIVESICULAR BODY; PARTICLE SIZE; PRIORITY JOURNAL; STATIC ELECTRICITY; SURFACE CHARGE; WESTERN BLOTTING; ZETA POTENTIAL;

APOPTOSIS; CO-DELIVERY SYSTEM; ELECTROSTATIC ASSEMBLY; LAYERED DOUBLE HYDROXIDE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; HYDROXIDES; NANOPARTICLES; RNA, SMALL INTERFERING;

EID: 84893691699     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.095     Document Type: Article

References (40)

1. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
2. Gillet J.P., Gottesman M. Mechanisms of multidrug resistance in cancer. Multi-drug resistance in cancer 2010, 47-76. Humana Press. J. Zhou (Ed.).
3. Saad M., Garbuzenko O.B., Minko T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine 2008, 3:761-776.
4. Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003, 3:330-338.
5. Chang R.S., Suh M.S., Kim S., Shim G., Lee S., Han S.S., et al. Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA. Biomaterials 2011, 32:9785-9795.
6. Tan S.J., Kiatwuthinon P., Roh Y.H., Kahn J.S., Luo D. Engineering nanocarriers for siRNA delivery. Small 2011, 7:841-856.
7. Khan M., Ong Z.Y., Wiradharma N., Attia A.B.E., Yang Y.Y. Advanced materials for co-delivery of drugs and genes in cancer therapy. Adv Healthc Mater 2012, 1:373-392.
8. Fan H., Hu Q.D., Xu F.J., Liang W.Q., Tang G.P., Yang W.T. In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL. Biomaterials 2012, 33:1428-1436.
9. Hu C.M.J., Aryal S., Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv 2010, 1:323-334.
10. Nakamura K., Abu Lila A.S., Matsunaga M., Doi Y., Ishida T., Kiwada H. A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA. Mol Ther 2011, 19:2040-2047.
11. Chen A.M., Zhang M., Wei D., Stueber D., Taratula O., Minko T., et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 2009, 5:2673-2677.
12. Wang H., Zhao Y., Wu Y., Hu Yl, Nan K., Nie G., et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 2011, 32:8281-8290.
13. Cheng D., Cao N., Chen J., Yu X., Shuai X. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat. Biomaterials 2012, 33:1170-1179.
14. Xu Z.P., Brateman P.S., Yarberry F. Layer double hydroxides. Handbook of layered materials 2004, 373. Marcel Dekker, Inc, New York. S.M. Auerbach, K.A. Carrado, P.K. Dutta (Eds.).
15. Ladewig K., Xu Z.P., Lu G.Q. Layered double hydroxide nanoparticles in gene and drug delivery. Expert Opin Drug Deliv 2009, 6:907-922.
16. Xu Z.P., Stevenson G., Lu C.Q., Lu G.Q., Bartlett P.F., Gray P. Stable suspension of layered double hydroxide nanoparticles in aqueous solution. J Am Chem Soc 2006, 128:36-37.
17. Choi S.J., Choi G.E., Oh J.M., Oh Y.J., Park M.C., Choy J.H. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance. J Mater Chem 2010, 20:9463-9469.
18. Chakraborty M., Dasgupta S., Sengupta S., Chakraborty J., Ghosh S., Ghosh J., et al. A facile synthetic strategy for Mg-Al layered double hydroxide material as nanocarrier for methotrexate. Ceram Int 2012, 38:941-949.
19. 4@DFUR-LDH submicro particles for magnetically controlled drug delivery and release. Chem Commun 2011, 47:908-910.
20. Choi S.J., Oh J.M., Choy J.H. Anticancer drug-layered hydroxide nanohybrids as potent cancer chemotherapy agents. J Phys Chem Solids 2008, 69:1528-1532.
21. Ladewig K., Niebert M., Xu Z.P., Gray P.P., Lu G.Q.M. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles. Biomaterials 2010, 31:1821-1829.
22. Wong Y., Markham K., Xu Z.P., Chen M., Lu G.Q., Bartlett P.F., et al. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials 2010, 31:8770-8779.
23. Choy J.H., Jung J.S., Oh J.M., Park M., Jeong J., Kang Y.K., et al. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 2004, 25:3059-3064.
24. Oh J.M., Park M., Kim S.T., Jung J.Y., Kang Y.G., Choy J.H. Efficient delivery of anticancer drug MTX through MTX-LDH nanohybrid system. J Phys Chem Solids 2006, 67:1024-1027.
25. Chen M., Cooper H.M., Zhou J.Z., Bartlett P.F., Xu Z.P. Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery. J Colloid Interface Sci 2013, 390:275-281.
26. Xu Z.P., Stevenson G., Lu C.Q., Lu G.Q. Dispersion and size control of layered double hydroxide nanoparticles in aqueous solutions. J Phys Chem B 2006, 110:16923-16929.
27. Liu C.X., Hou W.G., Li L.F., Li Y., Liu S.J. Synthesis and characterization of 5-fluorocytosine intercalated Zn-Al layered double hydroxide. J Solid State Chem 2008, 181:1792-1797.
28. Wang Z., Wang E., Gao L., Xu L. Synthesis and properties of Mg2Al layered double hydroxides containing 5-fluorouracil. J Solid State Chem 2005, 178:736-741.
29. Chen C.P., Yee L.K., Gong H., Zhang Y., Xu R. A facile synthesis of strong near infrared fluorescent layered double hydroxide nanovehicles with an anticancer drug for tumor optical imaging and therapy. Nanoscale 2013, 5:4314-4320.
30. Xu Z.P., Gu Z., Cheng X.X., Rasoul F., Whittaker A.K., Lu G.Q.M. Controlled release of ketorolac through nanocomposite films of hydrogel and LDH nanoparticles. J Nanopart Res 2011, 13:1253-1264.
31. Xu Z.P., Niebert M., Porazik K., Walker T.L., Cooper H.M., Middelberg A.P.J., et al. Subcellular compartment targeting of layered double hydroxide nanoparticles. J Control Release 2008, 130:86-94.
32. Yassin A.E., Anwer M.K., Mowafy H.A., El-Bagory I.M., Bayomi M.A., Alsarra I.A. Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 2010, 7:398-408.
33. Ladewig K., Niebert M., Xu Z.P., Gray P.P., Lu G.Q. Controlled preparation of layered double hydroxide nanoparticles and their application as gene delivery vehicles. Appl Clay Sci 2010, 48:280-289.
34. Oh J.M., Choi S.J., Kim S.T., Choy J.H. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug Chem 2006, 17:1411-1417.
35. Chumakova O.V., Liopo A.V., Evers B.M., Esenaliev R.O. Effect of 5-fluorouracil, optison and ultrasound on MCF-7 cell viability. Ultrasound Med Biol 2006, 32:751-758.
36. Chow L., Loo W. The differential effects of cyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker (CPP-32), proapoptotic protein (p21WAF-1) and anti-apoptotic protein (bcl-2) in breast cancer cells. Breast Cancer Res Treat 2003, 80:239-244.
37. Xiong X.B., Lavasanifar A. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 2011, 5:5202-5213.
38. Hu C.M.J., Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol 2012, 83:1104-1111.
39. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35:495-516.
40. Kang C.M., Suh Y., Jang I.S., Park S.C. Thymidine-dependent attenuation of the mitochondrial apoptotic pathway in adenosine-induced apoptosis of HL-60 cells. J Cancer Res Clin Oncol 2001, 127:570-576.